Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,5.2606520287606245e-40,117.47418738049713,10624.735402465276,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.6886693012321604e-37,0,0,67
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,8.66292873870635e-21,27.348269581056467,1263.3597154157226,"['NDUFB9', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",1.3904000625623691e-18,0,0,41
3,Nonalcoholic fatty liver disease WP4396,5.0807692840284146e-17,17.482045982950144,655.8998606963459,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",5.4364231339104035e-15,0,0,37
4,Mitochondrial complex I assembly model OXPHOS system WP4324,7.258867424993797e-12,inf,inf,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC1', 'TMEM186', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",5.825241108557522e-10,0,0,18
5,Oxidative phosphorylation WP623,5.50193307096576e-09,15.239929947460595,289.8355227356637,"['NDUFB9', 'ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'NDUFB10', 'NDUFA5', 'NDUFB5', 'NDUFA4', 'NDUFB2', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",3.532241031560018e-07,0,0,19
6,Mitochondrial CIV Assembly WP4922,2.5153304776677336e-06,11.131944444444445,143.52534372021884,"['COX8A', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX7C', 'COX6B1', 'SCO2', 'COX14']",0.00013457018055522375,0,0,14
7,Mitochondrial complex III assembly WP4921,1.1802723192579565e-05,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.0005412391635454344,0,0,8
8,Pyrimidine metabolism WP4022,0.022712460912151938,3.140893470790378,11.887784163395837,"['NT5C', 'POLD4', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2K', 'NME1', 'POLR2L']",0.9113374941000965,0,0,8
9,Nanoparticle triggered regulated necrosis WP2513,0.046900949511578575,9.378194207836456,28.69462360708883,"['TRADD', 'FADD', 'FTL']",0.9954296333986469,0,0,3
10,Selenium Micronutrient Network WP15,0.048524694810444115,2.5099656357388316,7.594358947233882,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'SELENOK', 'PTGS2', 'SEPHS2', 'SELENOH']",0.9954296333986469,0,0,8
11,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.05906947480605021,inf,inf,"['COX8A', 'GSTP1']",0.9954296333986469,0,0,2
12,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.05906947480605021,inf,inf,"['HOMER1', 'HRAS']",0.9954296333986469,0,0,2
13,CAMKK2  Pathway WP4874,0.05906947480605021,inf,inf,"['FIS1', 'MAP1LC3A']",0.9954296333986469,0,0,2
14,Cellular Proteostasis WP4918,0.05906947480605021,inf,inf,"['VBP1', 'PFDN5']",0.9954296333986469,0,0,2
15,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.05906947480605021,inf,inf,"['LDHA', 'HLA-DRA']",0.9954296333986469,0,0,2
16,DNA IR-double strand breaks and cellular response via ATM WP3959,0.06417239045745086,4.170648464163823,11.453360641334122,"['DCLRE1C', 'KAT5', 'CHEK2', 'BAX']",0.9954296333986469,0,0,4
17,Nanomaterial induced apoptosis WP2507,0.06417239045745086,4.170648464163823,11.453360641334122,"['ENDOG', 'BAX', 'CYCS', 'FADD']",0.9954296333986469,0,0,4
18,Cytosolic DNA-sensing pathway WP4655,0.07002473032954479,3.12991452991453,8.322151054874414,"['MAVS', 'TRADD', 'FADD', 'POLR2K', 'POLR2L']",0.9954296333986469,0,0,5
19,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.09625704714739149,4.686541737649063,10.969943329442737,"['MAP1LC3A', 'IGFBP5', 'TNFSF9']",0.9954296333986469,0,0,3
20,Ciliary landscape WP4352,0.11347487216932892,1.9275707110758658,4.194728989250933,"['EXOSC4', 'TTC30B', 'NDUFA5', 'COPS7A', 'MYL6B', 'RAB3IL1', 'COX6C', 'LSM4']",0.9954296333986469,0,0,8
21,Gastric acid production WP2596,0.1485511420941649,6.241496598639456,11.901447923429359,"['CCK', 'VIP']",0.9954296333986469,0,0,2
22,miRNA regulation of p53 pathway in prostate cancer WP3982,0.1485511420941649,6.241496598639456,11.901447923429359,"['CHEK2', 'BAX']",0.9954296333986469,0,0,2
23,Monoamine Transport WP727,0.1485511420941649,6.241496598639456,11.901447923429359,"['ADORA2A', 'IL1R1']",0.9954296333986469,0,0,2
24,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.1485511420941649,6.241496598639456,11.901447923429359,"['MAP1LC3A', 'FTL']",0.9954296333986469,0,0,2
25,Overview of nanoparticle effects WP3287,0.1485511420941649,6.241496598639456,11.901447923429359,"['BAX', 'PTGS2']",0.9954296333986469,0,0,2
26,"Relationship between inflammation, COX-2 and EGFR WP4483",0.1485511420941649,6.241496598639456,11.901447923429359,"['PTGS2', 'HRAS']",0.9954296333986469,0,0,2
27,Ferroptosis WP4313,0.15285615209618036,2.499658703071672,4.695003911860756,"['MAP1LC3A', 'GPX4', 'SAT2', 'FTL']",0.9954296333986469,0,0,4
28,mRNA Processing WP411,0.15285615209618036,2.499658703071672,4.695003911860756,"['LSM7', 'SNRPE', 'SRSF9', 'LSM2']",0.9954296333986469,0,0,4
29,Proteasome Degradation WP183,0.15285615209618036,2.499658703071672,4.695003911860756,"['PSMB6', 'H2AFZ', 'HLA-B', 'PSMB10']",0.9954296333986469,0,0,4
30,ATM Signaling Network in Development and Disease  WP3878,0.15857230765091815,3.122657580919932,5.750513174571546,"['DCLRE1C', 'KAT5', 'CHEK2']",0.9954296333986469,0,0,3
31,Copper homeostasis WP3286,0.15857230765091815,3.122657580919932,5.750513174571546,"['SCO2', 'COX17', 'ATOX1']",0.9954296333986469,0,0,3
32,Eukaryotic Transcription Initiation WP405,0.15857230765091815,3.122657580919932,5.750513174571546,"['TAF13', 'POLR2I', 'POLR2K']",0.9954296333986469,0,0,3
33,p38 MAPK Signaling Pathway WP400,0.15857230765091815,3.122657580919932,5.750513174571546,"['TRADD', 'DDIT3', 'HRAS']",0.9954296333986469,0,0,3
34,Apoptosis Modulation and Signaling WP1772,0.1713919051950532,1.876027397260274,3.3089418161711404,"['ENDOG', 'IL1R1', 'TRADD', 'CYCS', 'BAX', 'FADD']",0.9954296333986469,0,0,6
35,Integrated breast cancer pathway WP1984,0.19245067142567054,1.683731362976646,2.7746468600679943,"['CHEK2', 'TRADD', 'DCAKD', 'BAX', 'FADD', 'FAU', 'TGFBR2']",0.9954296333986469,0,0,7
36,TNF-alpha signaling pathway WP231,0.20807710876495564,2.0819112627986347,3.268281219062056,"['TRADD', 'BAX', 'FADD', 'HRAS']",0.9954296333986469,0,0,4
37,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.22937225386421972,2.340715502555366,3.4464906484730817,"['MAVS', 'TRADD', 'FADD']",0.9954296333986469,0,0,3
38,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.22937225386421972,2.340715502555366,3.4464906484730817,"['MAVS', 'TRADD', 'FADD']",0.9954296333986469,0,0,3
39,15q11.2 copy number variation syndrome WP4940,0.24319844913375546,inf,inf,['TUBGCP4'],0.9954296333986469,0,0,1
40,Serotonin Transporter Activity WP1455,0.24319844913375546,inf,inf,['IL1R1'],0.9954296333986469,0,0,1
41,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.24319844913375546,inf,inf,['IDH3B'],0.9954296333986469,0,0,1
42,Vitamin B12 Disorders WP4271,0.24319844913375546,inf,inf,['CUBN'],0.9954296333986469,0,0,1
43,EV release from cardiac cells and their functional effects WP3297,0.24319844913375546,inf,inf,['RGS16'],0.9954296333986469,0,0,1
44,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.24319844913375546,inf,inf,['RPS6'],0.9954296333986469,0,0,1
45,Globo Sphingolipid Metabolism WP1424,0.24319844913375546,inf,inf,['FUT2'],0.9954296333986469,0,0,1
46,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.24319844913375546,inf,inf,['ELOB'],0.9954296333986469,0,0,1
47,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.24319844913375546,inf,inf,['MAP1LC3A'],0.9954296333986469,0,0,1
48,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.24319844913375546,inf,inf,['HRAS'],0.9954296333986469,0,0,1
49,Insulin signaling in adipocytes (diabetic condition) WP3635,0.24319844913375546,inf,inf,['RPS6'],0.9954296333986469,0,0,1
50,Insulin signaling in adipocytes (normal condition) WP3634,0.24319844913375546,inf,inf,['RPS6'],0.9954296333986469,0,0,1
51,LDLRAD4 and what we know about it WP4904,0.24319844913375546,inf,inf,['TGFBR2'],0.9954296333986469,0,0,1
52,Macrophage markers WP4146,0.24319844913375546,inf,inf,['CD74'],0.9954296333986469,0,0,1
53,Mitochondrial CII Assembly WP4920,0.24319844913375546,inf,inf,['SDHAF1'],0.9954296333986469,0,0,1
54,Nanoparticle triggered autophagic cell death WP2509,0.24319844913375546,inf,inf,['MAP1LC3A'],0.9954296333986469,0,0,1
55,Non-homologous end joining WP438,0.24319844913375546,inf,inf,['DCLRE1C'],0.9954296333986469,0,0,1
56,SARS coronavirus and innate immunity WP4912,0.24319844913375546,inf,inf,['MAVS'],0.9954296333986469,0,0,1
57,Apoptosis Modulation by HSP70 WP384,0.25020133756707524,3.119047619047619,4.321407211460623,"['CYCS', 'FADD']",0.9954296333986469,0,0,2
58,BDNF-TrkB Signaling WP3676,0.25020133756707524,3.119047619047619,4.321407211460623,"['HOMER1', 'HRAS']",0.9954296333986469,0,0,2
59,White fat cell differentiation WP4149,0.25020133756707524,3.119047619047619,4.321407211460623,"['DDIT3', 'NR2F2']",0.9954296333986469,0,0,2
60,GABA receptor Signaling WP4159,0.25020133756707524,3.119047619047619,4.321407211460623,"['SLC32A1', 'AP2M1']",0.9954296333986469,0,0,2
61,Genes targeted by miRNAs in adipocytes WP1992,0.25020133756707524,3.119047619047619,4.321407211460623,"['TMSB4X', 'ERG']",0.9954296333986469,0,0,2
62,Major receptors targeted by epinephrine and norepinephrine WP4589,0.25020133756707524,3.119047619047619,4.321407211460623,"['ADRA1D', 'ADRA2A']",0.9954296333986469,0,0,2
63,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.25020133756707524,3.119047619047619,4.321407211460623,"['RAB13', 'FERMT3']",0.9954296333986469,0,0,2
64,SARS-CoV-2 mitochondrial interactions WP5038,0.25020133756707524,3.119047619047619,4.321407211460623,"['NDUFB9', 'MAVS']",0.9954296333986469,0,0,2
65,Apoptosis WP254,0.26783016648850666,1.7835202340321794,2.349613491617418,"['TRADD', 'CYCS', 'BAX', 'FADD']",0.9954296333986469,0,0,4
66,Male infertility WP4673,0.26783016648850666,1.7835202340321794,2.349613491617418,"['HLA-DRA', 'PEX10', 'HORMAD1', 'TEX15']",0.9954296333986469,0,0,4
67,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.3044395271539428,1.871550255536627,2.2258025446228955,"['PPP1R14B', 'MAP1LC3A', 'DDIT3']",0.9954296333986469,0,0,3
68,Leptin signaling pathway WP2034,0.3044395271539428,1.871550255536627,2.2258025446228955,"['RPS6', 'BAX', 'HRAS']",0.9954296333986469,0,0,3
69,Oxidative Damage WP3941,0.3044395271539428,1.871550255536627,2.2258025446228955,"['C1QB', 'C5AR1', 'CYCS']",0.9954296333986469,0,0,3
70,DNA Repair Pathways Full Network WP4946,0.33005438524687153,1.5597269624573378,1.7289539600173773,"['POLD4', 'DCLRE1C', 'CENPX', 'APEX1']",0.9954296333986469,0,0,4
71,IL-18 signaling pathway WP4754,0.34497875026481145,1.208840272351825,1.2865354071186001,"['ADAMTS5', 'CD81', 'TMSB4X', 'RGS16', 'COX17', 'CYCS', 'BAX', 'NDUFC1', 'FADD', 'LTB', 'PTGS2', 'RND2']",0.9954296333986469,0,0,12
72,Type 2 papillary renal cell carcinoma WP4241,0.35283083869862214,2.078231292517007,2.1650318382882254,"['EPAS1', 'ELOB']",0.9954296333986469,0,0,2
73,DNA Replication WP466,0.35283083869862214,2.078231292517007,2.1650318382882254,"['POLD4', 'GMNN']",0.9954296333986469,0,0,2
74,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.35283083869862214,2.078231292517007,2.1650318382882254,"['HRAS', 'TGFBR2']",0.9954296333986469,0,0,2
75,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.35283083869862214,2.078231292517007,2.1650318382882254,"['LDHA', 'RPS6']",0.9954296333986469,0,0,2
76,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.35283083869862214,2.078231292517007,2.1650318382882254,"['BAX', 'FADD']",0.9954296333986469,0,0,2
77,IL-2 signaling pathway WP49,0.35283083869862214,2.078231292517007,2.1650318382882254,"['RPS6', 'HRAS']",0.9954296333986469,0,0,2
78,Interleukin-11 Signaling Pathway WP2332,0.35283083869862214,2.078231292517007,2.1650318382882254,"['RPS6', 'HRAS']",0.9954296333986469,0,0,2
79,Kallmann's Syndrome WP5074,0.35283083869862214,2.078231292517007,2.1650318382882254,"['TMEM98', 'CHD7']",0.9954296333986469,0,0,2
80,Prostaglandin Synthesis and Regulation WP98,0.35283083869862214,2.078231292517007,2.1650318382882254,"['ANXA2', 'PTGS2']",0.9954296333986469,0,0,2
81,Rett syndrome causing genes WP4312,0.35283083869862214,2.078231292517007,2.1650318382882254,"['IMPDH2', 'TBL1X']",0.9954296333986469,0,0,2
82,Hepatitis B infection WP4666,0.3551355077544671,1.3370841487279843,1.3842241873886405,"['MAVS', 'CYCS', 'BAX', 'FADD', 'HRAS', 'TGFBR2']",0.9954296333986469,0,0,6
83,16p11.2 proximal deletion syndrome WP4949,0.38023119365454816,1.5587734241908007,1.507296189647584,"['ASPHD1', 'SEZ6L2', 'CCT7']",0.9954296333986469,0,0,3
84,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.38023119365454816,1.5587734241908007,1.507296189647584,"['LDHA', 'BAX', 'PTGS2']",0.9954296333986469,0,0,3
85,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.39288005639761675,1.3856655290102389,1.2945592865630982,"['CYCS', 'BAX', 'PTGS2', 'TGFBR2']",0.9954296333986469,0,0,4
86,Head and Neck Squamous Cell Carcinoma WP4674,0.39288005639761675,1.3856655290102389,1.2945592865630982,"['RPS6', 'FADD', 'HRAS', 'TGFBR2']",0.9954296333986469,0,0,4
87,Gastrin signaling pathway WP4659,0.4000051841803807,1.2991452991452992,1.1903779595648953,"['KAT5', 'ANXA2', 'RPS6', 'PTGS2', 'HRAS']",0.9954296333986469,0,0,5
88,Serotonin and anxiety WP3947,0.4273272609848914,3.1154499151103567,2.6487715316579226,['CRH'],0.9954296333986469,0,0,1
89,Serotonin and anxiety-related events WP3944,0.4273272609848914,3.1154499151103567,2.6487715316579226,['CRH'],0.9954296333986469,0,0,1
90,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.4273272609848914,3.1154499151103567,2.6487715316579226,['HRAS'],0.9954296333986469,0,0,1
91,Splicing factor NOVA regulated synaptic proteins WP4148,0.4273272609848914,3.1154499151103567,2.6487715316579226,['NTNG1'],0.9954296333986469,0,0,1
92,Amyotrophic lateral sclerosis (ALS) WP2447,0.4273272609848914,3.1154499151103567,2.6487715316579226,['BAX'],0.9954296333986469,0,0,1
93,Aspirin and miRNAs WP4707,0.4273272609848914,3.1154499151103567,2.6487715316579226,['PTGS2'],0.9954296333986469,0,0,1
94,Biomarkers for pyrimidine metabolism disorders WP4584,0.4273272609848914,3.1154499151103567,2.6487715316579226,['NT5C'],0.9954296333986469,0,0,1
95,Canonical and non-canonical TGF-B signaling WP3874,0.4273272609848914,3.1154499151103567,2.6487715316579226,['TGFBR2'],0.9954296333986469,0,0,1
96,Transcription factor regulation in adipogenesis WP3599,0.4273272609848914,3.1154499151103567,2.6487715316579226,['PCK2'],0.9954296333986469,0,0,1
97,Transcriptional cascade regulating adipogenesis WP4211,0.4273272609848914,3.1154499151103567,2.6487715316579226,['DDIT3'],0.9954296333986469,0,0,1
98,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.4273272609848914,3.1154499151103567,2.6487715316579226,['CCK'],0.9954296333986469,0,0,1
99,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.4273272609848914,3.1154499151103567,2.6487715316579226,['MAVS'],0.9954296333986469,0,0,1
100,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.4273272609848914,3.1154499151103567,2.6487715316579226,['SYTL3'],0.9954296333986469,0,0,1
101,Disruption of postsynaptic signaling by CNV WP4875,0.4273272609848914,3.1154499151103567,2.6487715316579226,['HOMER1'],0.9954296333986469,0,0,1
102,Dual hijack model of Vif in HIV infection WP3300,0.4273272609848914,3.1154499151103567,2.6487715316579226,['ELOB'],0.9954296333986469,0,0,1
103,Ebstein-Barr virus LMP1 signaling WP262,0.4273272609848914,3.1154499151103567,2.6487715316579226,['TRADD'],0.9954296333986469,0,0,1
104,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.4273272609848914,3.1154499151103567,2.6487715316579226,['PTGS2'],0.9954296333986469,0,0,1
105,Energy Metabolism WP1541,0.4273272609848914,3.1154499151103567,2.6487715316579226,['UCP3'],0.9954296333986469,0,0,1
106,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.4273272609848914,3.1154499151103567,2.6487715316579226,['MAFF'],0.9954296333986469,0,0,1
107,Fatty acid transporters WP5061,0.4273272609848914,3.1154499151103567,2.6487715316579226,['FABP6'],0.9954296333986469,0,0,1
108,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.4273272609848914,3.1154499151103567,2.6487715316579226,['H2AFZ'],0.9954296333986469,0,0,1
109,Homologous recombination WP186,0.4273272609848914,3.1154499151103567,2.6487715316579226,['POLD4'],0.9954296333986469,0,0,1
110,MAPK Cascade WP422,0.4273272609848914,3.1154499151103567,2.6487715316579226,['HRAS'],0.9954296333986469,0,0,1
111,Metabolism of alpha-linolenic acid WP4586,0.4273272609848914,3.1154499151103567,2.6487715316579226,['PTGS2'],0.9954296333986469,0,0,1
112,MTHFR deficiency WP4288,0.4273272609848914,3.1154499151103567,2.6487715316579226,['CYCS'],0.9954296333986469,0,0,1
113,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.4273272609848914,3.1154499151103567,2.6487715316579226,['SCO2'],0.9954296333986469,0,0,1
114,Nuclear receptors WP170,0.4273272609848914,3.1154499151103567,2.6487715316579226,['NR2F2'],0.9954296333986469,0,0,1
115,Nucleotide GPCRs WP80,0.4273272609848914,3.1154499151103567,2.6487715316579226,['ADORA2A'],0.9954296333986469,0,0,1
116,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.4273272609848914,3.1154499151103567,2.6487715316579226,['MAVS'],0.9954296333986469,0,0,1
117,Peroxiredoxin 2 induced ovarian failure WP4873,0.4273272609848914,3.1154499151103567,2.6487715316579226,['BAX'],0.9954296333986469,0,0,1
118,Phosphoinositides metabolism WP4971,0.4273272609848914,3.1154499151103567,2.6487715316579226,['PIP4P1'],0.9954296333986469,0,0,1
119,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.4273272609848914,3.1154499151103567,2.6487715316579226,['HRAS'],0.9954296333986469,0,0,1
120,Pyrimidine metabolism and related diseases WP4225,0.4273272609848914,3.1154499151103567,2.6487715316579226,['NT5C'],0.9954296333986469,0,0,1
121,Integrated Cancer Pathway WP1971,0.4499600610097392,1.5578231292517006,1.2440720261512515,"['CHEK2', 'BAX']",0.9954296333986469,0,0,2
122,MET in type 1 papillary renal cell carcinoma WP4205,0.4499600610097392,1.5578231292517006,1.2440720261512515,"['RPL11', 'HRAS']",0.9954296333986469,0,0,2
123,Pathways affected in adenoid cystic carcinoma WP3651,0.4499600610097392,1.5578231292517006,1.2440720261512515,"['CHEK2', 'HRAS']",0.9954296333986469,0,0,2
124,PPAR signaling pathway WP3942,0.4499600610097392,1.5578231292517006,1.2440720261512515,"['FABP6', 'PCK2']",0.9954296333986469,0,0,2
125,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.45401148484800774,1.3353614018009248,1.0544451416689709,"['APEX1', 'RPS6', 'HRAS']",0.9954296333986469,0,0,3
126,"GPCRs, Class A Rhodopsin-like WP455",0.4922615524285804,1.083520095622292,0.767939551066507,"['NPFFR1', 'ADORA2A', 'GPR22', 'NPY1R', 'ADRA1D', 'OR6A2', 'MCHR1', 'ADRA2A']",0.9954296333986469,0,0,8
127,Alzheimer's disease WP2059,0.5238294408312133,1.167802385008518,0.7550883424318474,"['ATP5MD', 'CYCS', 'FADD']",0.9954296333986469,0,0,3
128,Canonical and non-canonical Notch signaling WP3845,0.5381951297856465,1.245578231292517,0.7716781758101383,"['MAML2', 'DLK2']",0.9954296333986469,0,0,2
129,Computational Model of Aerobic Glycolysis WP4629,0.5381951297856465,1.245578231292517,0.7716781758101383,"['LDHA', 'PFKM']",0.9954296333986469,0,0,2
130,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5381951297856465,1.245578231292517,0.7716781758101383,"['CYCS', 'FADD']",0.9954296333986469,0,0,2
131,Fragile X Syndrome  WP4549,0.5381951297856465,1.245578231292517,0.7716781758101383,"['HOMER1', 'AP2M1']",0.9954296333986469,0,0,2
132,Kit receptor signaling pathway WP304,0.5381951297856465,1.245578231292517,0.7716781758101383,"['RPS6', 'HRAS']",0.9954296333986469,0,0,2
133,MECP2 and Associated Rett Syndrome WP3584,0.5381951297856465,1.245578231292517,0.7716781758101383,"['SST', 'RPS6']",0.9954296333986469,0,0,2
134,Monoamine GPCRs WP58,0.5381951297856465,1.245578231292517,0.7716781758101383,"['ADRA1D', 'ADRA2A']",0.9954296333986469,0,0,2
135,VEGFA-VEGFR2 Signaling Pathway WP3888,0.5456061603755611,1.0002497502497503,0.6060091946629211,"['SET', 'RPS6', 'PTGS2', 'RPL10A', 'RPL7', 'LDHA', 'RPL18A', 'TMSB4X', 'MMRN2', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'ERG', 'FADD', 'CCT7', 'HRAS', 'CGNL1']",0.9954296333986469,0,0,18
136,16p11.2 distal deletion syndrome WP4950,0.566715197971485,1.5568760611205432,0.8841474206742549,['CD81'],0.9954296333986469,0,0,1
137,Signal transduction through IL1R WP4496,0.566715197971485,1.5568760611205432,0.8841474206742549,['IL1R1'],0.9954296333986469,0,0,1
138,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.566715197971485,1.5568760611205432,0.8841474206742549,['VIP'],0.9954296333986469,0,0,1
139,Vitamin D-sensitive calcium signaling in depression WP4698,0.566715197971485,1.5568760611205432,0.8841474206742549,['GPX4'],0.9954296333986469,0,0,1
140,EDA signaling in hair follicle development WP3930,0.566715197971485,1.5568760611205432,0.8841474206742549,['LTB'],0.9954296333986469,0,0,1
141,Eicosanoid Synthesis WP167,0.566715197971485,1.5568760611205432,0.8841474206742549,['PTGS2'],0.9954296333986469,0,0,1
142,Glutathione metabolism WP100,0.566715197971485,1.5568760611205432,0.8841474206742549,['GPX4'],0.9954296333986469,0,0,1
143,Glycosaminoglycan degradation WP4815,0.566715197971485,1.5568760611205432,0.8841474206742549,['SGSH'],0.9954296333986469,0,0,1
144,Glycosylation and related congenital defects WP4521,0.566715197971485,1.5568760611205432,0.8841474206742549,['DPM3'],0.9954296333986469,0,0,1
145,Histone Modifications WP2369,0.566715197971485,1.5568760611205432,0.8841474206742549,['SET'],0.9954296333986469,0,0,1
146,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.566715197971485,1.5568760611205432,0.8841474206742549,['MAVS'],0.9954296333986469,0,0,1
147,IL1 and megakaryocytes in obesity WP2865,0.566715197971485,1.5568760611205432,0.8841474206742549,['IL1R1'],0.9954296333986469,0,0,1
148,IL17 signaling pathway WP2112,0.566715197971485,1.5568760611205432,0.8841474206742549,['IL17RE'],0.9954296333986469,0,0,1
149,Interferon type I signaling pathways WP585,0.566715197971485,1.5568760611205432,0.8841474206742549,['RPS6'],0.9954296333986469,0,0,1
150,Joubert Syndrome WP4656,0.566715197971485,1.5568760611205432,0.8841474206742549,['KAT5'],0.9954296333986469,0,0,1
151,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.566715197971485,1.5568760611205432,0.8841474206742549,['BAX'],0.9954296333986469,0,0,1
152,Nanoparticle-mediated activation of receptor signaling WP2643,0.566715197971485,1.5568760611205432,0.8841474206742549,['HRAS'],0.9954296333986469,0,0,1
153,NO/cGMP/PKG mediated Neuroprotection WP4008,0.566715197971485,1.5568760611205432,0.8841474206742549,['CYCS'],0.9954296333986469,0,0,1
154,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.566715197971485,1.5568760611205432,0.8841474206742549,['HLA-DRA'],0.9954296333986469,0,0,1
155,Purinergic signaling WP4900,0.566715197971485,1.5568760611205432,0.8841474206742549,['ADORA2A'],0.9954296333986469,0,0,1
156,RalA downstream regulated genes WP2290,0.566715197971485,1.5568760611205432,0.8841474206742549,['HRAS'],0.9954296333986469,0,0,1
157,Acute viral myocarditis WP4298,0.5884210817751417,1.0374787052810903,0.5501878863779269,"['ENDOG', 'CYCS', 'BAX']",0.9954296333986469,0,0,3
158,DNA damage response WP707,0.5884210817751417,1.0374787052810903,0.5501878863779269,"['CHEK2', 'CYCS', 'BAX']",0.9954296333986469,0,0,3
159,Endometrial cancer WP4155,0.5884210817751417,1.0374787052810903,0.5501878863779269,"['BAX', 'FGF1', 'HRAS']",0.9954296333986469,0,0,3
160,miRNA regulation of DNA damage response WP1530,0.5884210817751417,1.0374787052810903,0.5501878863779269,"['CHEK2', 'CYCS', 'BAX']",0.9954296333986469,0,0,3
161,Non-small cell lung cancer WP4255,0.5884210817751417,1.0374787052810903,0.5501878863779269,"['CYCS', 'BAX', 'HRAS']",0.9954296333986469,0,0,3
162,Spinal Cord Injury WP2431,0.5921448458686746,0.9825162220620043,0.5148424323412836,"['C1QB', 'IL1R1', 'APEX1', 'OMG', 'LTB', 'PTGS2']",0.9954296333986469,0,0,6
163,Aryl Hydrocarbon Receptor Netpath WP2586,0.6161136027358737,1.0374149659863945,0.502444875135952,"['PTGS2', 'HRAS']",0.9954296333986469,0,0,2
164,Synaptic Vesicle Pathway WP2267,0.6161136027358737,1.0374149659863945,0.502444875135952,"['SLC32A1', 'AP2M1']",0.9954296333986469,0,0,2
165,Base Excision Repair WP4752,0.6161136027358737,1.0374149659863945,0.502444875135952,"['POLD4', 'APEX1']",0.9954296333986469,0,0,2
166,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6161136027358737,1.0374149659863945,0.502444875135952,"['IFITM3', 'DDIT3']",0.9954296333986469,0,0,2
167,Modulators of TCR signaling and T cell activation WP5072,0.6161136027358737,1.0374149659863945,0.502444875135952,"['NDUFB10', 'ELOB']",0.9954296333986469,0,0,2
168,Phosphodiesterases in neuronal function WP4222,0.6161136027358737,1.0374149659863945,0.502444875135952,"['PDE10A', 'ADORA2A']",0.9954296333986469,0,0,2
169,Prolactin Signaling Pathway WP2037,0.6161136027358737,1.0374149659863945,0.502444875135952,"['RPS6', 'HRAS']",0.9954296333986469,0,0,2
170,Complement system WP2806,0.6470833405419154,0.9332197614991482,0.4062120676754274,"['FKBP2', 'RPS19', 'C5AR1']",0.9954296333986469,0,0,3
171,DNA damage response (only ATM dependent) WP710,0.6470833405419154,0.9332197614991482,0.4062120676754274,"['BAX', 'HRAS', 'PCK2']",0.9954296333986469,0,0,3
172,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6470833405419154,0.9332197614991482,0.4062120676754274,"['RPS6', 'BAX', 'HRAS']",0.9954296333986469,0,0,3
173,Genotoxicity pathway WP4286,0.6470833405419154,0.9332197614991482,0.4062120676754274,"['RPS27', 'BLOC1S2', 'TRIAP1']",0.9954296333986469,0,0,3
174,Allograft Rejection WP2328,0.6714485878445985,0.8883471477328133,0.3538445073723024,"['C1QB', 'COL5A1', 'HLA-B', 'HLA-DRA']",0.9954296333986469,0,0,4
175,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.6722197083559273,1.0373514431239388,0.41200491928024185,['EPAS1'],0.9954296333986469,0,0,1
176,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.6722197083559273,1.0373514431239388,0.41200491928024185,['IL1R1'],0.9954296333986469,0,0,1
177,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.6722197083559273,1.0373514431239388,0.41200491928024185,['SST'],0.9954296333986469,0,0,1
178,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.6722197083559273,1.0373514431239388,0.41200491928024185,['RPS6'],0.9954296333986469,0,0,1
179,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6722197083559273,1.0373514431239388,0.41200491928024185,['FADD'],0.9954296333986469,0,0,1
180,Cannabinoid receptor signaling WP3869,0.6722197083559273,1.0373514431239388,0.41200491928024185,['ADORA2A'],0.9954296333986469,0,0,1
181,TP53 network WP1742,0.6722197083559273,1.0373514431239388,0.41200491928024185,['BAX'],0.9954296333986469,0,0,1
182,Type II interferon signaling (IFNG) WP619,0.6722197083559273,1.0373514431239388,0.41200491928024185,['HLA-B'],0.9954296333986469,0,0,1
183,Endothelin Pathways WP2197,0.6722197083559273,1.0373514431239388,0.41200491928024185,['NPY1R'],0.9954296333986469,0,0,1
184,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6722197083559273,1.0373514431239388,0.41200491928024185,['HRAS'],0.9954296333986469,0,0,1
185,ERK Pathway in Huntington's Disease WP3853,0.6722197083559273,1.0373514431239388,0.41200491928024185,['HRAS'],0.9954296333986469,0,0,1
186,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.6722197083559273,1.0373514431239388,0.41200491928024185,['FGF1'],0.9954296333986469,0,0,1
187,HIF1A and PPARG regulation of glycolysis WP2456,0.6722197083559273,1.0373514431239388,0.41200491928024185,['LDHA'],0.9954296333986469,0,0,1
188,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.6722197083559273,1.0373514431239388,0.41200491928024185,['TGFBR2'],0.9954296333986469,0,0,1
189,IL-1 signaling pathway WP195,0.6722197083559273,1.0373514431239388,0.41200491928024185,['IL1R1'],0.9954296333986469,0,0,1
190,IL-5 signaling pathway WP127,0.6722197083559273,1.0373514431239388,0.41200491928024185,['RPS6'],0.9954296333986469,0,0,1
191,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.6722197083559273,1.0373514431239388,0.41200491928024185,['TGFBR2'],0.9954296333986469,0,0,1
192,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6722197083559273,1.0373514431239388,0.41200491928024185,['HRAS'],0.9954296333986469,0,0,1
193,Mammalian disorder of sexual development WP4842,0.6722197083559273,1.0373514431239388,0.41200491928024185,['EMX2'],0.9954296333986469,0,0,1
194,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.6722197083559273,1.0373514431239388,0.41200491928024185,['ANXA2'],0.9954296333986469,0,0,1
195,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.6722197083559273,1.0373514431239388,0.41200491928024185,['VEGFB'],0.9954296333986469,0,0,1
196,miR-509-3p alteration of YAP1/ECM axis WP3967,0.6722197083559273,1.0373514431239388,0.41200491928024185,['COL5A1'],0.9954296333986469,0,0,1
197,miRNA targets in ECM and membrane receptors WP2911,0.6722197083559273,1.0373514431239388,0.41200491928024185,['COL5A1'],0.9954296333986469,0,0,1
198,Nucleotide metabolism WP404,0.6722197083559273,1.0373514431239388,0.41200491928024185,['NME2'],0.9954296333986469,0,0,1
199,PDGF Pathway WP2526,0.6722197083559273,1.0373514431239388,0.41200491928024185,['HRAS'],0.9954296333986469,0,0,1
200,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.6722197083559273,1.0373514431239388,0.41200491928024185,['PTGS2'],0.9954296333986469,0,0,1
201,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6722197083559273,1.0373514431239388,0.41200491928024185,['BAX'],0.9954296333986469,0,0,1
202,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6722197083559273,1.0373514431239388,0.41200491928024185,['BAX'],0.9954296333986469,0,0,1
203,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.6722197083559273,1.0373514431239388,0.41200491928024185,['ANAPC11'],0.9954296333986469,0,0,1
204,Sleep regulation WP3591,0.6835085106113675,0.8887269193391643,0.3381749647487358,"['ADORA2A', 'CRH']",0.9954296333986469,0,0,2
205,Amino Acid metabolism WP3925,0.6835085106113675,0.8887269193391643,0.3381749647487358,"['LDHA', 'MARS2']",0.9954296333986469,0,0,2
206,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.6835085106113675,0.8887269193391643,0.3381749647487358,"['HRAS', 'TGFBR2']",0.9954296333986469,0,0,2
207,TGF-beta Receptor Signaling WP560,0.6835085106113675,0.8887269193391643,0.3381749647487358,"['HRAS', 'TGFBR2']",0.9954296333986469,0,0,2
208,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6835085106113675,0.8887269193391643,0.3381749647487358,"['IFI27L2', 'HRAS']",0.9954296333986469,0,0,2
209,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6835085106113675,0.8887269193391643,0.3381749647487358,"['BAX', 'HRAS']",0.9954296333986469,0,0,2
210,MAPK Signaling Pathway WP382,0.6932340327306676,0.8697770154373928,0.3186755369098307,"['DUSP4', 'IL1R1', 'DDIT3', 'RASGRF2', 'FGF1', 'HRAS', 'TGFBR2']",0.9954296333986469,0,0,7
211,22q11.2 copy number variation syndrome WP4657,0.6995463036990901,0.8479169893139229,0.3029804896620283,"['RANBP1', 'MRPL40', 'THAP7']",0.9954296333986469,0,0,3
212,Androgen receptor signaling pathway WP138,0.6995463036990901,0.8479169893139229,0.3029804896620283,"['KAT5', 'BAG1', 'STUB1']",0.9954296333986469,0,0,3
213,Regulation of Actin Cytoskeleton WP51,0.6995463036990901,0.8479169893139229,0.3029804896620283,"['DIAPH3', 'TMSB4X', 'FGF1']",0.9954296333986469,0,0,3
214,7q11.23 copy number variation syndrome WP4932,0.7408826975192819,0.7772108843537415,0.23309562399017328,"['ATP5F1E', 'ATP5MC1']",0.9954296333986469,0,0,2
215,Thermogenesis WP4321,0.7408826975192819,0.7772108843537415,0.23309562399017328,"['RPS6', 'HRAS']",0.9954296333986469,0,0,2
216,Complement and Coagulation Cascades WP558,0.7408826975192819,0.7772108843537415,0.23309562399017328,"['C1QB', 'C5AR1']",0.9954296333986469,0,0,2
217,Ectoderm Differentiation WP2858,0.7408826975192819,0.7772108843537415,0.23309562399017328,"['NR2F2', 'TBL1X']",0.9954296333986469,0,0,2
218,"GPCRs, Other WP117",0.7408826975192819,0.7772108843537415,0.23309562399017328,"['ADORA2A', 'ADRA1D']",0.9954296333986469,0,0,2
219,EGF/EGFR signaling pathway WP437,0.745857400390361,0.7768313458262351,0.22778314701869282,"['NDUFA13', 'HRAS', 'AP2M1']",0.9954296333986469,0,0,3
220,Endoderm differentiation WP2853,0.745857400390361,0.7768313458262351,0.22778314701869282,"['DUSP4', 'TCEAL2', 'NME1']",0.9954296333986469,0,0,3
221,Complement Activation WP545,0.7520668199022205,0.7775891341256367,0.22155855186568252,['C1QB'],0.9954296333986469,0,0,1
222,Cytokines and Inflammatory Response WP530,0.7520668199022205,0.7775891341256367,0.22155855186568252,['HLA-DRA'],0.9954296333986469,0,0,1
223,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.7520668199022205,0.7775891341256367,0.22155855186568252,['CD81'],0.9954296333986469,0,0,1
224,GDNF/RET signaling axis WP4830,0.7520668199022205,0.7775891341256367,0.22155855186568252,['SALL1'],0.9954296333986469,0,0,1
225,Genes related to primary cilium development (based on CRISPR) WP4536,0.7520668199022205,0.7775891341256367,0.22155855186568252,['TTC30B'],0.9954296333986469,0,0,1
226,Glycolysis in senescence WP5049,0.7520668199022205,0.7775891341256367,0.22155855186568252,['LDHA'],0.9954296333986469,0,0,1
227,"GPCRs, Class B Secretin-like WP334",0.7520668199022205,0.7775891341256367,0.22155855186568252,['ADGRL4'],0.9954296333986469,0,0,1
228,Integrin-mediated Cell Adhesion WP185,0.7520668199022205,0.7775891341256367,0.22155855186568252,['HRAS'],0.9954296333986469,0,0,1
229,Microglia Pathogen Phagocytosis Pathway WP3937,0.7520668199022205,0.7775891341256367,0.22155855186568252,['C1QB'],0.9954296333986469,0,0,1
230,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.7520668199022205,0.7775891341256367,0.22155855186568252,['OMG'],0.9954296333986469,0,0,1
231,PDGFR-beta pathway WP3972,0.7520668199022205,0.7775891341256367,0.22155855186568252,['HRAS'],0.9954296333986469,0,0,1
232,Myometrial relaxation and contraction pathways WP289,0.7644056892675974,0.7760683760683761,0.2084959097952613,"['IGFBP5', 'RGS16', 'MAFF', 'CRH', 'IGFBP6']",0.9954296333986469,0,0,5
233,Small cell lung cancer WP4658,0.7862833720982364,0.716681955182807,0.17231759545419525,"['CYCS', 'BAX', 'PTGS2']",0.9954296333986469,0,0,3
234,Ebola Virus Pathway on Host WP4217,0.7862833720982364,0.716681955182807,0.17231759545419525,"['HLA-B', 'VPS11', 'HLA-DRA']",0.9954296333986469,0,0,3
235,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7891166828125962,0.6904761904761905,0.16353312812287826,"['RPS6', 'HRAS']",0.9954296333986469,0,0,2
236,Melanoma WP4685,0.7891166828125962,0.6904761904761905,0.16353312812287826,"['BAX', 'HRAS']",0.9954296333986469,0,0,2
237,NRF2 pathway WP2884,0.795427021032288,0.7387057387057387,0.16907214404249518,"['GSTP1', 'MAFF', 'SLC5A3', 'FTL', 'TGFBR2']",0.9954296333986469,0,0,5
238,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8124880672172814,0.6217317487266554,0.12910511649957368,['HRAS'],0.9954296333986469,0,0,1
239,AGE/RAGE pathway WP2324,0.8124880672172814,0.6217317487266554,0.12910511649957368,['CYCS'],0.9954296333986469,0,0,1
240,Alpha 6 Beta 4 signaling pathway WP244,0.8124880672172814,0.6217317487266554,0.12910511649957368,['HRAS'],0.9954296333986469,0,0,1
241,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8124880672172814,0.6217317487266554,0.12910511649957368,['HRAS'],0.9954296333986469,0,0,1
242,ATM Signaling Pathway WP2516,0.8124880672172814,0.6217317487266554,0.12910511649957368,['CHEK2'],0.9954296333986469,0,0,1
243,Translation Factors WP107,0.8124880672172814,0.6217317487266554,0.12910511649957368,['EEF1B2'],0.9954296333986469,0,0,1
244,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8124880672172814,0.6217317487266554,0.12910511649957368,['RPS6'],0.9954296333986469,0,0,1
245,Unfolded protein response WP4925,0.8124880672172814,0.6217317487266554,0.12910511649957368,['DDIT3'],0.9954296333986469,0,0,1
246,Vitamin A and carotenoid metabolism WP716,0.8124880672172814,0.6217317487266554,0.12910511649957368,['RBP4'],0.9954296333986469,0,0,1
247,Cori Cycle WP1946,0.8124880672172814,0.6217317487266554,0.12910511649957368,['LDHA'],0.9954296333986469,0,0,1
248,DNA Mismatch Repair WP531,0.8124880672172814,0.6217317487266554,0.12910511649957368,['POLD4'],0.9954296333986469,0,0,1
249,Hypertrophy Model WP516,0.8124880672172814,0.6217317487266554,0.12910511649957368,['IL1R1'],0.9954296333986469,0,0,1
250,IL-3 signaling pathway WP286,0.8124880672172814,0.6217317487266554,0.12910511649957368,['HRAS'],0.9954296333986469,0,0,1
251,IL-6 signaling pathway WP364,0.8124880672172814,0.6217317487266554,0.12910511649957368,['VIP'],0.9954296333986469,0,0,1
252,Nephrotic syndrome WP4758,0.8124880672172814,0.6217317487266554,0.12910511649957368,['CUBN'],0.9954296333986469,0,0,1
253,Nucleotide Excision Repair WP4753,0.8124880672172814,0.6217317487266554,0.12910511649957368,['POLD4'],0.9954296333986469,0,0,1
254,One-carbon metabolism and related pathways WP3940,0.8124880672172814,0.6217317487266554,0.12910511649957368,['GPX4'],0.9954296333986469,0,0,1
255,Photodynamic therapy-induced unfolded protein response WP3613,0.8124880672172814,0.6217317487266554,0.12910511649957368,['DDIT3'],0.9954296333986469,0,0,1
256,Circadian rhythm related genes WP3594,0.8205686813806607,0.689419795221843,0.1363380490558042,"['HOMER1', 'ADORA2A', 'CRH', 'RPS27A']",0.9954296333986469,0,0,4
257,Ciliopathies WP4803,0.8212313366387329,0.6651253346312972,0.13099672398222822,"['CCDC65', 'AK7', 'CCDC28B']",0.9954296333986469,0,0,3
258,Ras signaling WP4223,0.8212313366387329,0.6651253346312972,0.13099672398222822,"['RASGRF2', 'RASAL1', 'HRAS']",0.9954296333986469,0,0,3
259,Exercise-induced Circadian Regulation WP410,0.829255730052305,0.6210884353741497,0.11628433273337971,"['GSTP1', 'UCP3']",0.9954296333986469,0,0,2
260,Glycolysis and Gluconeogenesis WP534,0.829255730052305,0.6210884353741497,0.11628433273337971,"['LDHA', 'PFKM']",0.9954296333986469,0,0,2
261,Peptide GPCRs WP24,0.829255730052305,0.6210884353741497,0.11628433273337971,"['C5AR1', 'NPY1R']",0.9954296333986469,0,0,2
262,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8322852585706648,0.7228130360205832,0.13269404466626492,"['COL5A1', 'EPAS1', 'COL11A1', 'RPS6', 'VEGFB', 'FGF1', 'HRAS']",0.9954296333986469,0,0,7
263,Toll-like Receptor Signaling Pathway WP75,0.8582034534882961,0.5178268251273345,0.07918301376823365,['FADD'],0.9954296333986469,0,0,1
264,Vitamin B12 metabolism WP1533,0.8582034534882961,0.5178268251273345,0.07918301376823365,['CUBN'],0.9954296333986469,0,0,1
265,DNA IR-damage and cellular response via ATR WP4016,0.8582034534882961,0.5178268251273345,0.07918301376823365,['CHEK2'],0.9954296333986469,0,0,1
266,G Protein Signaling Pathways WP35,0.8582034534882961,0.5178268251273345,0.07918301376823365,['HRAS'],0.9954296333986469,0,0,1
267,Heart Development WP1591,0.8582034534882961,0.5178268251273345,0.07918301376823365,['VEGFB'],0.9954296333986469,0,0,1
268,Hepatitis C and Hepatocellular Carcinoma WP3646,0.8582034534882961,0.5178268251273345,0.07918301376823365,['PTGS2'],0.9954296333986469,0,0,1
269,p53 transcriptional gene network WP4963,0.8582034534882961,0.5178268251273345,0.07918301376823365,['BAX'],0.9954296333986469,0,0,1
270,Parkinson's disease pathway WP2371,0.8582034534882961,0.5178268251273345,0.07918301376823365,['CYCS'],0.9954296333986469,0,0,1
271,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8582034534882961,0.5178268251273345,0.07918301376823365,['GSTP1'],0.9954296333986469,0,0,1
272,Pre-implantation embryo WP3527,0.8582034534882961,0.5178268251273345,0.07918301376823365,['DDIT3'],0.9954296333986469,0,0,1
273,B Cell Receptor Signaling Pathway WP23,0.862377909214878,0.5643166357452072,0.08355367739627123,"['CD81', 'HRAS']",0.9954296333986469,0,0,2
274,Pancreatic adenocarcinoma pathway WP4263,0.862377909214878,0.5643166357452072,0.08355367739627123,"['BAX', 'TGFBR2']",0.9954296333986469,0,0,2
275,Senescence and Autophagy in Cancer WP615,0.8766735358165624,0.5813458262350937,0.07651709051257005,"['MAP1LC3A', 'IGFBP5', 'HRAS']",0.9954296333986469,0,0,3
276,Development of ureteric collection system WP5053,0.8927876162745749,0.44360902255639095,0.050308172395321475,['SALL1'],0.9954296333986469,0,0,1
277,Differentiation Pathway WP2848,0.8927876162745749,0.44360902255639095,0.050308172395321475,['FGF1'],0.9954296333986469,0,0,1
278,Folate Metabolism WP176,0.8927876162745749,0.44360902255639095,0.050308172395321475,['GPX4'],0.9954296333986469,0,0,1
279,Genes controlling nephrogenesis WP4823,0.8927876162745749,0.44360902255639095,0.050308172395321475,['EMX2'],0.9954296333986469,0,0,1
280,Lung fibrosis WP3624,0.8927876162745749,0.44360902255639095,0.050308172395321475,['FGF1'],0.9954296333986469,0,0,1
281,Notch Signaling Pathway Netpath WP61,0.8927876162745749,0.44360902255639095,0.050308172395321475,['MAML2'],0.9954296333986469,0,0,1
282,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.8927876162745749,0.44360902255639095,0.050308172395321475,['NDUFA13'],0.9954296333986469,0,0,1
283,ESC Pluripotency Pathways WP3931,0.9116177549899428,0.4769754055468341,0.04413668308146675,"['FGF1', 'HRAS']",0.9954296333986469,0,0,2
284,Oncostatin M Signaling Pathway WP2374,0.9116177549899428,0.4769754055468341,0.04413668308146675,"['RPS6', 'HRAS']",0.9954296333986469,0,0,2
285,Pathways in clear cell renal cell carcinoma WP4018,0.9116177549899428,0.4769754055468341,0.04413668308146675,"['LDHA', 'PFKM']",0.9954296333986469,0,0,2
286,Proximal tubule transport WP4917,0.9116177549899428,0.4769754055468341,0.04413668308146675,"['SLC7A9', 'SLC26A6']",0.9954296333986469,0,0,2
287,Adipogenesis WP236,0.9163032644193029,0.5161839863713799,0.045118555375632065,"['EPAS1', 'DDIT3', 'PCK2']",0.9954296333986469,0,0,3
288,Aryl Hydrocarbon Receptor Pathway WP2873,0.9189474053335783,0.38794567062818336,0.03279164650605176,['BAX'],0.9954296333986469,0,0,1
289,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9189474053335783,0.38794567062818336,0.03279164650605176,['TMSB4X'],0.9954296333986469,0,0,1
290,Bladder cancer WP2828,0.9189474053335783,0.38794567062818336,0.03279164650605176,['HRAS'],0.9954296333986469,0,0,1
291,Chemokine signaling pathway WP3929,0.9189474053335783,0.38794567062818336,0.03279164650605176,['HRAS'],0.9954296333986469,0,0,1
292,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9189474053335783,0.38794567062818336,0.03279164650605176,['ADAMTS5'],0.9954296333986469,0,0,1
293,Endochondral Ossification WP474,0.9189474053335783,0.38794567062818336,0.03279164650605176,['ADAMTS5'],0.9954296333986469,0,0,1
294,Retinoblastoma gene in cancer WP2446,0.9189474053335783,0.38794567062818336,0.03279164650605176,['H2AFZ'],0.9954296333986469,0,0,1
295,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9295225960023488,0.4426627793974733,0.03235163840019213,"['HRAS', 'TGFBR2']",0.9954296333986469,0,0,2
296,ErbB signaling pathway WP673,0.9387322769178212,0.34465195246179964,0.021790604367864334,['HRAS'],0.9954296333986469,0,0,1
297,Mesodermal commitment pathway WP2857,0.9387322769178212,0.34465195246179964,0.021790604367864334,['RPL38'],0.9954296333986469,0,0,1
298,Metabolic reprogramming in colon cancer WP4290,0.9387322769178212,0.34465195246179964,0.021790604367864334,['LDHA'],0.9954296333986469,0,0,1
299,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9387322769178212,0.34465195246179964,0.021790604367864334,['BAX'],0.9954296333986469,0,0,1
300,Regulation of toll-like receptor signaling pathway WP1449,0.9387322769178212,0.34465195246179964,0.021790604367864334,['FADD'],0.9954296333986469,0,0,1
301,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.943961361550053,0.4129251700680272,0.02381341282385676,"['RPS6', 'HRAS']",0.9954296333986469,0,0,2
302,Breast cancer pathway WP4262,0.9439866567339681,0.46405451448040885,0.026749609348742244,"['BAX', 'FGF1', 'HRAS']",0.9954296333986469,0,0,3
303,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9536937441357165,0.3100169779286927,0.01469873638642898,['RBP4'],0.9954296333986469,0,0,1
304,Cell cycle WP179,0.9555579863192236,0.3869047619047619,0.01758862480202809,"['CHEK2', 'ANAPC11']",0.9954296333986469,0,0,2
305,T-cell receptor (TCR) signaling pathway WP69,0.9650062028204754,0.28167927149251426,0.01003362687355937,['HRAS'],0.9954296333986469,0,0,1
306,Glioblastoma signaling pathways WP2261,0.9650062028204754,0.28167927149251426,0.01003362687355937,['HRAS'],0.9954296333986469,0,0,1
307,Glucocorticoid Receptor Pathway WP2880,0.9650062028204754,0.28167927149251426,0.01003362687355937,['PTGS2'],0.9954296333986469,0,0,1
308,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.9650062028204754,0.28167927149251426,0.01003362687355937,['STUB1'],0.9954296333986469,0,0,1
309,Metapathway biotransformation Phase I and II WP702,0.970004705347423,0.4028590474779646,0.012268813100632384,"['GPX4', 'GSTP1', 'GAL3ST3']",0.9954296333986469,0,0,3
310,Insulin Signaling WP481,0.9722414220911973,0.3435374149659864,0.009670965990572905,"['HRAS', 'PFKM']",0.9954296333986469,0,0,2
311,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.9735584767559973,0.25806451612903225,0.00691545481309431,['CARD14'],0.9954296333986469,0,0,1
312,Hippo-Merlin Signaling Dysregulation WP4541,0.9735584767559973,0.25806451612903225,0.00691545481309431,['HRAS'],0.9954296333986469,0,0,1
313,Vitamin D Receptor Pathway WP2877,0.9757672464005518,0.3858603066439523,0.00946561560493879,"['ADAMTS5', 'IGFBP5', 'ZNF257']",0.9954296333986469,0,0,3
314,Corticotropin-releasing hormone signaling pathway WP2355,0.9800231695219415,0.23808280005223978,0.0048042883518399455,['CRH'],0.9954296333986469,0,0,1
315,PI3K-Akt signaling pathway WP4172,0.9805925459012036,0.4398046398046398,0.008619401881564777,"['RPS6', 'VEGFB', 'FGF1', 'HRAS', 'PCK2']",0.9954296333986469,0,0,5
316,Calcium Regulation in the Cardiac Cell WP536,0.9828005713687404,0.308843537414966,0.005358144124504275,"['RGS16', 'ADRA1D']",0.9954296333986469,0,0,2
317,Nuclear Receptors Meta-Pathway WP2882,0.9830255258173554,0.47787307032590054,0.008181278673233625,"['GSTP1', 'MAFF', 'BAX', 'PTGS2', 'SLC5A3', 'FTL', 'TGFBR2']",0.9954296333986469,0,0,7
318,Focal Adhesion WP306,0.9935254030306713,0.2568027210884354,0.0016681001038414886,"['VEGFB', 'HRAS']",0.998405717011882,0,0,2
319,TGF-beta Signaling Pathway WP366,0.9950915079133714,0.17147707979626486,0.0008437663978248747,['TGFBR2'],0.998405717011882,0,0,1
320,Osteoblast differentiation WP4787,0.9962940862676888,0.1623626128138683,0.0006028195262191279,['FGF1'],0.998405717011882,0,0,1
321,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.998405717011882,0.13999073931162218,0.0002233629534055793,['SST'],0.998405717011882,0,0,1
